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1. Introduction 
There is evidence that psoriasis is principally a T cell-mediated skin disease. The interaction 
between T cells and keratinocytes via cytokines probably plays a very important role in the 
pathogenic process (Lee & Cooper, 2006). However, little is known about the initial stimulus 
that leads to the abnormal T-cell activation.  
Yeasts of the genus Malassezia are now considered synonymous with those previously 
named Pityrosporum, which are members of the normal cutaneous microbiota from humans 
and other warm-blooded animals. They have also been associated with several skin diseases 
such as pityriasis versicolor, seborrheic dermatitis and atopic dermatitis (Gupta et al., 2004; 
Ashbee 2007).  
Although streptococcal infection is the commonest and best delineated infective trigger for 
psoriasis, fungal infections have been noted on occasion to cause an exacerbation of 
psoriasis or psoriatic arthritis (Fry & Baker, 2007). 
The role of Malassezia species in psoriasis is still undetermined, but several reports have 
associated these lipophilic yeasts with the development of skin lesions in psoriasis. Mostly 
of these studied are treatment studies, showing the efficacy of antifungal drugs, both 
topical and systemic, in the treatment of the disease (Rosenberg & Belew, 1982; Alford et 
al., 1986). 
Currently, the genus Malassezia includes 14 species, which have been identified 
traditionally based on their morphology and biochemical features (Cafarchia et al., 
2011). Since the description of new species a number of studies have evolved to 
elucidate the role of the different species in the ecology and pathogenicity in a range of 
dermatoses, in which variable results have been reported from different geographical 
regions.  
2. Malassezia yeasts 
2.1 Description and natural habitats 
The genus Malassezia (former Pityrosporum) belongs to basidiomycetous yeasts and is 
classified in the Malasseziales (Ustilaginomycetes, Basidiomycota) (Boekhout & Gueho, 2003). 
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Malassezia yeasts are part of the normal cutaneous commensal flora. However, under the 
influence of predisposing factors these yeasts are able to cause a number of cutaneous and 
systemic diseases in humans and different animal species. Unlike many other 
microorganisms, Malassezia yeasts are rarely found in the environment. Their natural habitat 
is primarily the skin of most warm-blooded vertebrates (Midgley, 2000). 
Malassezia yeasts have an affinity for lipids as substrates and the term ‘lipophilic yeasts’ is 
frequently used to identify the genus. Due to their dependence on lipids for survival, they 
are most often found in sebum rich areas of the skin such as scalp, face and the trunk. Less 
frequently, they may be also found on other areas of the body including arms, legs and 
genitalia. 
Colonization with Malassezia may occur as early as neonatal period and increases after 
puberty, which is related to the increase in skin surface lipids that results from higher 
sebaceous gland activity during this period. Their density varies depending on age, body 
site, geographic area, and the presence of normal or diseased skin (Ashbee, 2006). 
2.2 Historical review and taxonomy 
The taxonomy of Malassezia has been confused because yeasts are dimorphic, existing in 
both yeast and mycelial (hyphal) forms, depending on culture conditions.  
For many years two taxonomy systems existed. The yeast phase was originally described as 
Pityrosporum and the mycelial phase as Malassezia, with two species M. furfur and M. 
pachydermatis, before they were unified in 1986 with both phases included in Malassezia 
(Cannon, 1986). 
On the basis of genome differences, in 1990, the third species M. sympodialis was described 
(Simmons & Gueho, 1990), and some years later, with the use of new molecular 
techniques, the genus was taxonomically revised and enlarged with four new species: M. 
slooffiae, M. globosa, M. obtusa and M. restricta (Gueho et al., 1996). M. pachydermatis is the 
only non lipid-depended species confirmed to be associated with animals, while 
remaining species are obligatory lipophilic and found primarily in humans (Guillot & 
Bond, 1999).  
Furthermore, in last few years some new species have been isolated from human (M. 
dermatis, M. japonica and M. yamotensis) and animal skin (M. nana, M. caprae and M. equina, 
M. cuniculi) (Sugita et al., 2002; Sugita et al, 2003; Sugita et al, 2004; Hirai et al., 2004; 
Cabañes et al., 2007; Cabañes et al., 2011). At present, 14 species of Malassezia have been 
identified.  
The different species of Malassezia yeasts that are known so far are shown in Table 1. No 
doubt that additional new species will be identified from both humans and animals in close 
future. 
2.3 Biological, cultural and immunological characteristics 
The different Malassezia species are distinguished based on their morphology, growth 
characteristics, enzyme activities, as well as by molecular characteristics.  
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M. furfur Baillon 1889 Healthy skin




M. pachydermatis (Weidman) Dodge 
1925 
 
Systemic infections Healthy skin: mainly 
dogs and cats 
Skin diseases: 
seborrheic dermatitis 
and otitis in dogs 
M. sympodialis Simmons & Guého 
1990 
Healthy skin
Skin diseases: atopic 
dermatitis
Healthy skin 
Skin diseases: otitis 
in cats
M. slooffiae Guillot, Midgley & 
Guého 1996 
Healthy skin: 
external ear canal 
Skin diseases: 
pityriasis versicolor
Healthy skin: pigs 
Skin diseases: 
dermatitis in goats 




Skin disease: mainly 
pityriasis versicolor 
Healthy skin 
Skin lesions: otitis in 
cats 
M. obtusa Midgley, Guillot &
Guého 1996 
Healthy skin
Skin diseases: mainly 
pityriasis versicolor
M. restricta Guého, Guillot & 
Midgley 1996 
Healthy skin
Skin diseases: mainly 
seborrheic dermatitis 
and scalp psoriasis
M. dermatis Sugita, Takashima, 
Nishikawa & Shinoda 
2002
Healthy skin
Skin diseases: atopic 
dermatitis
M. japonica Sugita, Takashima, 
Kodama, Tsuboi & 
Nishikawa 2003 
Healthy skin
Skin diseases: atopic 
dermatitis 
M. yamatoensis Sugita, Takashima, 









Skin diseases: cats 
and cows 
M. caprae Cabanes & Boekhout
2007
Healthy skin: goats 
M. equina Cabanes & Boekhout
2007 
Healthy skin: horses 
M. cuniculi Cabanes, Vega & 
Castella 2011 
Healthy skin: rabits 
Table 1. Malassezia species isolated from humans and animals 
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The fungus is dimorphic, existing in both saprophytic yeast and a parasitic mycelial form. 
The yeast form is most commonly associated with normal skin and predominates in culture, 
although hyphae may be seen with some species (Saadatzadeh et al., 2001).  
For direct demonstration of the yeasts, the specimen is collected from the clinical lesions by 
scraping or tape stripping and a potassium hydroxide mount is prepared. The cells are 
morphologically variable, occurring in round, oval or cylindrical forms. They show the 
production of blastoconidia by a process of repetitive monopolar or sympodial budding. 
Direct microscopy of the pityriasis versicolor scales reveals predominantly hyphae with 
clusters of yeast cells (spaghetti and meatball appearance), due to the phase transition from 
yeast to mycelium seen in this disease (Figure 1). 
 
Fig. 1. The typical appearance of the hyphae and spores of Malassezia in the scales of 
pityriasis versicolor 
The colonies of Malassezia spp. are raised, dull, creamy yellow and have a characteristic 
brittle texture (Figure 2). The characteristic morphological features of Malassezia yeasts 
include thick, multi-layered cell wall which is surrounded by a lamellar layer which 
contains lipids (Gueho et al., 1996). 
 
Fig. 2. The colonies of M. globosa on modified Dixon agar 
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Malasezia species produce a wide range of enzymes, including lipases, phospholipases and 
hydrolase. The lipases are essential in providing the lipids required for growth in vitro and 
in vivo. All species of Malassezia with the exception of M. pachydermatis, are lipid-dependent 
due to an inability to synthesize long-chain saturated fatty acids (Nazzaro Porro et al., 1986; 
Juntachai et al., 2009). 
To differentiate among the Malassezia species, cultures should be done in special media 
(Leeming and Notman agar or modified Dixon agar), except for M. pachydermatis, the only 
one that is able to grow in Sabouraud agar (Guillot et al., 1996).  
However, difficulties in cultivating Malassezia organisms may limit the analyses and bias the 
observations (Batra et al., 2005). Thus, molecular approaches, particularly analyses of 
ribosomal genes and internal transcribed regions, have been used for detection, 
identification, and characterization of Malassezia species (Cafarchia et al., 2011). 
Malassezia has the ability to stimulate the immune system via classical and alternative 
complement pathways, acting as an adjuvant and elicits both humoral and cellular immune 
response. In contrast, it is able to resist phagocytic killing by neutrophils and downregulate 
cytokine responses when co-cultured with peripheral blood mononuclear cells. With the 
interaction of yeasts with keratinocytes they induce the production of different cytokines, 
especially IL-6, IL-8 and IL-10 (Asbbee 2006; Blanco & Garcia 2008). 
2.4 Human diseased associated with Malassezia yeasts 
In recent years, the genus Malassezia has come to be considered important in the etiology of 
various skin and systemic diseases. Both immunocompetent and immunosuppressed 
patients may be affected by this type of infection. In immunologically competent hosts, 
Malassezia species are implicated in the pathogenesis of variety of skin infections such as 
pityriasis versicolor, Malassezia folliculitis, seborrheic dermatitis, and, rarely, in a range of 
other dermatological disorders (Midgley 2000; Gupta et al., 2004). In contrast, in 
immunocompromised patients, including patients with AIDS, immune-haematological, 
oncological, and solid organ and bone marrow transplant recipients, these yeasts have been 
associated with catheter-related fungemia, sepsis and a variety of deeply invasive infections 
(Tragiannidis et al., 2010). 
The etiological role of Malassezia yeasts in pityriasis versicolor is unquestioned; the organism 
found in the lesions is predominantly in its mycelial phase (Crespo et al., 1999; Gupta et al., 
2001; Prohic & Ozegovic, 2007; Trabelsi et al., 2010).  
In the case of the other skin diseases such as seborrheic dermatitis, Malassezia folliculitis, 
confluent and reticulate papillomatosis, atopic dermatitis, and psoriasis, the pathogenic role 
of Malassezia yeasts remains less clear; transition of the yeast cells to their pathogenic hyphal 
form cannot be clearly demonstrated (Gupta et al., 2004; Ashbee 2007).  
With the revision of the taxonomy of Malassezia, new questions have been raised about their 
significance and relative prevalence in various dermatologic disorders.  
The diseases where Malassezia species have been implicated and the most frequent species 
isolated are summarized in Table 2. 
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Oportunitic systemic infections 
M. globosa, M. furfur 
M. restricta, M. globosa, M. sympodialis 
M. globosa, M. restricta 
M. sympodialis, M. globosa, M. furfur 
M. furfur, M. sympodialis 




M. globosa, M. sympodialis 
M. furfur, M. pachydermatis 




The pathogenesis of psoriasis is quite complex, but there is compelling evidence that T-cell 
activation and resultant overproduction of proinflammatory cytokines are critical for the 
development and maintenance of psoriatic lesion (Lee & Cooper, 2006; Tokura et al., 2010).  
A variety of different environmental factors are accepted as of importance in provoking new 
episodes of psoriasis or in modifying preexisting diseases. They include trauma, infections, 
drugs and psychological stress (Fry & Baker, 2007). However, definite proof that particular 
autoantigens, antigens or both contribute to the immunopathology of psoriasis is still 
lacking.  
Nevertheless, a number of keratins microbial proteins have been postulated as putative 
candidates (Jones et al., 2004). Keratin (K) 13 has significant homology with K17, which was 
previously identified as candidate autoantigen based on the presence of both antibodies and 
T cells that cross-react with a streptococcus M protein (Gudmundsdottir et al, 1999). 
Furthermore, K13 is not present in adult skin normally, but is present in fetal skin (van 
Muijen et al, 1987), and is up-regulated during trauma or inflammation. (Kallioinen et al, 
1995). This could potentially provide an explanation for the Koebner phenomenon, where 
new psoriasis plaques can flare up at or old lesions spread to a site of injury. 
Superantigens may exacerbate psoriasis by stimulating T cells to initiate the pathogenic 
events of psoriasis. Microorganisms such as β-haemolytic streptococci, Staphylococcus aureus 
and Candida albicans have been suggested as external triggers that activate large number of T 
cells and release proinflammatory cytokines, particularly tumour necrosis factor (TNF)-a 
(Macias et al., 2011). Massive cytokine production could lead to reduced vascular tone, 
resulting in widespread organ hypoperfusion, acidosis and multiorgan failure. 
3.1.1 Bacterial superantigens 
Streptococcal superantigens appear to play a direct role in the pathogenesis of guttate 
psoriasis. It is well documented that streptococcal infection can trigger guttate psoriasis or 
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exacerbate chronic plaque psoriasis, possibly through the release of bacterial superantigenic 
toxins, now known as streptococcal pyrogenic exotoxins (Gudjonsson et al., 2003).  
The high level of streptococcal throat cultures and sore throats in chronic plaque psoriasis 
implies that patients with chronic plaque psoriasis are extremely efficient at streptococcal 
throat carriage. It was purposed that part of the psoriatic genotype protects against death 
during epidemics of invasive streptococcal infections, but at the expense of increased 
streptococcal carriage and predisposition to the development of psoriasis (McFadden et al., 
2009). 
Furthermore, T lymphocytes specific for group A streptococci have been isolated and cloned 
from the skin of guttate psoriatic patients suggesting a role of these cells in the disease 
process (Baker et al., 1993; Valdimarsson et al., 1995). 
These observations indicate that streptococcal infections are major etiological factors for 
psoriasis in genetically predisposed individuals. However, this does not exclude a role for 
other microorganisms in the disease. 
3.1.2 Fungal superantigens 
Fungal organisms have also been suggested as external triggers that release factors which 
serve as superantigens and stimulate T cells to initiate the pathogenic events of psoriasis 
(Waldman et al., 2001) 
Regarding the prevalence of Candida albicans infections in psoriasis, data are controversial. 
Some authors found no increase in the prevalence of Candida in intertriginous area of 
psoriatic patients as compared with healthy individuals (Flytstrom et al., 2003; Leibovici et 
al., 2008). As ketoconazole appeared to be helpful in the treatment of some inverse psoriasis 
patients, the authors suggested an anti-inflammatory effect, which may explain some of its 
beneficial effects irrespective of Candida infection. However, Rebora reported the presence of 
Candida in the intertriginous areas of psoriatic patients and commented that Candida present 
in the intertriginous areas disappears when replaced by Gram negative bacteria, but leaves a 
kobnerising effect (Rebora, 2004). 
4. Malassezia and psoriasis 
4.1 Historical review 
Rivolta made the first association of the lipophilic yeasts and psoriasis in 1873 (Rivolta, 
1873). He reported on round double-contoured budding cells in the epidermis of a patient 
with psoriasis and named them Cryptococcus psoriasis.  
The role of Malassezia yeasts in psoriasis is still undetermined, but there are several 
reports indicating that these microorganisms are able to elicit psoriasiform lesions in 
both human and animals. Rosenberg reported that, after heavy dense suspensions of 
Malassezia were applied to the shaved rabbits skin, lesions both grossly and 
microscopically similar to psoriasis developed. The lesions persisted as long as 
Malassezia continued to be applied but otherwise resolved within 3 to 4 days (Rosenberg 
et al., 1980).  
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The same group claimed to be able to induce lesions that developed following patch testing 
with sonicates of heat killed Malassezia cells on nonlesional skin of patients with psoriasis 
and biopsy specimens showed features consistent with psoriasis (Lober et al., 1982). 
Although a Koebner phenomenon could not be excluded, their hypothesis was that psoriasis 
was produced by Malassezia yeasts through activation of the alternative pathway of 
complement, and also activated by other microorganisms and endotoxins. 
Elewski reported of a patient developing guttate psoriasis in sites of Malassezia folliculitis. In 
this case, pustules transformed into guttate lesions prior and during erythromycin therapy 
but resolved when ketoconazole was applied (Elewski, 1990). Although this transformation 
could also be Koebner phenomenon, this case report supported the proposal that psoriasis 
may be included in Malassezia-associated diseases. 
The beneficial effect of both oral and topical ketoconazole, followed by reduction of yeasts, 
indicates that Malassezia yeasts may represent another antigenic stimulus in psoriasis 
(Rosenberg & Belew, 1982). Although this antimycotic drug may act through a direct mode 
of action, it has also been shown that it can suppress Malassezia-induced proliferation of 
lymphocytes in psoriatic patients and thus reduce the response to the antigenic stimulation 
in skin lesions (Alford et al., 1986). 
More recent studies have indicated that Malassezia yeasts cause exacerbation of psoriasis by 
triggering the release of cytokines, in particular IL-8 through a Toll-like receptor 2-mediated 
pathway (Baroni et al., 2006). However, convincing evidence of their importance in the 
pathogenesis of the disease is still lacking. 
4.2 Isolation to the species level 
Since the description of the new species some studies have focused on their distribution in 
various diseases, and also in psoriasis.  
The identification of Malassezia yeasts to a species level is of no diagnostic value in skin 
diseases, as the same species form an integral part of normal cutaneous microflora in 
humans. However, it is of great importance to determine which species are implicated in 
certain skin disease and whether there is variation in the distribution of the yeasts with 
clinical data, body site, origin of the population, etc. 
The results of the in vitro susceptibility studies have shown variations in susceptibility of the 
seven Malassezia species to ketoconazole, variconazole, itraconazole, and terbinafine. Strains 
of M.furfur, M.globosa, and M.obtusa were more tolerant to terbinafine than other species, 
while M.sympodialis was found to be highly susceptible (Gupta et al., 2000). Therefore, 
correct identification of Malassezia species is required for the selection of appropriate 
antifungal therapy. 
Some authors have stated that M. globosa predominate (Prohic, 2003; Zomorodian et al., 
2008) whilst others have found M. restricta (Amaya et al., 2007) or M. sympodialis (Hernandez 
et al., 2003) to be the most common species in scalp lesions of psoriasis. 
The higher detection rate of Malassezia species was observed using molecular determination 
method than by conventional culture methods. These variations may be attributed to the 
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different sampling technique and inadequate determination of the relative proportion of 
species on the skin, or the consent ability of the fungus to grow in each specified medium 
that have impact on the range of species recovered. Geographical and racial factors were 
also suspected as playing a part in the results yielded by conventional culture systems 
(Sandstrom Falk et al., 2005). 
4.3 Immune response to Malassezia yeasts 
Psoriasis is also known to have a strong genetic component. Therefore, several studies have 
examined the immune responses of psoriasis patients to Malassezia. 
It has been shown that these individuals have immunologic responses to both Malassezia 
yeasts and to proteins derived from them. T cells reactive to the various morphological 
variants of yeasts have been isolated from lesional skin, but they were not specific for the 
disease (Baker et al., 1997). Furthermore, antibodies to proteins from Malassezia have been 
reported in patients with psoriasis, but not healthy subjects (Squiquera et al., 1994; Liang 
et al., 2003). These antibodies were subsequently shown to recognize the N-
acetylglucosamine terminals of glycoproteins present in Malassezia (Mathow et al., 1996). 
However, both of these proteins are recognized by sera from patients with atopic 
dermatitis (Lintu et al., 1997; Nissen et al., 1998), and so they are not specific markers for 
psoriasis. 
Kanda et al. found that Malassezia yeasts induce Th-1 and Th2-related cytokine, chemokine 
and prostaglandin E2 production in peripheral blood mononuclear cells from patients with 
psoriasis vulgaris (Kanda et al., 2002). 
Furtermore, Malassezia can invade cultured human keratinocytes, modulate 
proinflammatory and immunomodulatory cytokine synthesis, and affect the expression of 
cutaneous proteins (Baroni et al., 2001). A study done by same authors added to the 
evidence of its role in the hyperproliferation seen in psoriasis. Using western blot analysis 
they found that Malassezia can induce the overproduction of molecules involved in cell 
migration and hyperproliferation, thereby favoring the exacerbation of psoriasis. (Baroni et 
al., 2004).  
Malassezia species differ in their ability to induce cytokine production by human 
keratinocytes, which is reflected in the different inflammatory responses in Malassezia-
associated dermatoses, resulting in varied clinical and pathological manifestations. 
A study examining the chemotaxis of neutrophils from psoriatic patients and controls 
demonstrated the presence of Malassezia-derived soluble components with chemo-
attractant properties for polymorphonuclear leukocytes of psoriatic patients (Bunse & 
Mahrle, 1996).  
Psoriatic lesions often develop at sites of trauma (the Koebner phenomenon) (Mohla & 
Brodell, 1999), and the increased chemotactic response of neutrophils to Malassezia was 
suggested to play a role in this event. 
Kesavan et al. have shown that Malassezia yeasts significantly reduce the production of pro-
inflammatory cytokines what is related to the presence of lipid-rich microfibrilar layer 
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surrounding yeast cells (Kesavan et al., 1998) High quantity of lipid may prevent the yeast 
cell from inducing inflammation what is in consistent with their commensal status. Further 
study by the same group demonstrated that extraction of cell wall lipids reversed their 
capacity to reduce the level of pro-inflammatory cytokines (Kesavan et al., 2000). In 
psoriasis, however, these yeasts fail to posses lipid layer due to abnormalities in enzymes 
involved in lipid formation in stratum corneum of patients with psoriasis.  
5. Conclusion 
The role that Malassezia plays in psoriasis is, as yet, undetermined. Although it may 
contribute to the inflammation associated with the disease, via complement activation and 
neutrophil recruitment, convincing evidence that it is of prime importance in the 
pathogenesis of the disease is still lacking.  
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